IONELA IACOBAS to Sirolimus
This is a "connection" page, showing publications IONELA IACOBAS has written about Sirolimus.
Connection Strength
1.730
-
Decreased vascularization of retroperitoneal kaposiform hemangioendothelioma induced by treatment with sirolimus explains relief of symptoms. Clin Imaging. 2015 May-Jun; 39(3):529-32.
Score: 0.428
-
Oral rapamycin in the treatment of patients with hamartoma syndromes and PTEN mutation. Pediatr Blood Cancer. 2011 Aug; 57(2):321-3.
Score: 0.327
-
Sirolimus for vascular anomalies in the first year of life: a systematic review. J Perinatol. 2024 Aug; 44(8):1087-1097.
Score: 0.200
-
No Association of Sirolimus with Wound Complications in Children With Vascular Anomalies. J Pediatr Surg. 2023 Aug; 58(8):1555-1559.
Score: 0.185
-
Sirolimus efficacy in the treatment of critically ill infants with congenital primary chylous effusions. Pediatr Blood Cancer. 2022 02; 69(2):e29510.
Score: 0.173
-
Clinical variability in multifocal lymphangioendotheliomatosis with thrombocytopenia: a review of the literature. Pediatr Hematol Oncol. 2021 May; 38(4):367-377.
Score: 0.164
-
Combination percutaneous and medical management of cardiac rhabdomyomas obstructing tricuspid valve inflow: Case report. J Neonatal Perinatal Med. 2021; 14(1):143-148.
Score: 0.162
-
Response to sirolimus in capillary lymphatic venous malformations and associated syndromes: Impact on symptomatology, quality of life, and radiographic response. Pediatr Blood Cancer. 2023 04; 70(4):e30215.
Score: 0.047
-
Institutional Management of Abdominal Lymphatic Malformations: Evolution of Treatment Over a Decade. J Surg Res. 2022 12; 280:296-303.
Score: 0.045